ProQR Therapeutics (PRQR) Long-Term Debt Issuances (2013 - 2021)

ProQR Therapeutics' Long-Term Debt Issuances history runs 9 years deep, the most recent figure standing at $30.3 million for Q4 2021.

• In Q4 2021, Long-Term Debt Issuances rose 10111.27% year-over-year to $30.3 million; the TTM figure through Dec 2021 stood at $31.6 million (up 93.38% YoY), while the FY2021 annual figure was $1.3 million, up 103.53% from the prior year.
• Long-Term Debt Issuances came in at $30.3 million for Q4 2021 at ProQR Therapeutics, up from $334917.6 in the prior quarter.
• In the past five years, Long-Term Debt Issuances ranged from a high of $30.3 million in Q4 2021 to a low of $117.51 in Q3 2017.
• A 5-year average of $3.1 million and a median of $217063.1 in 2018 frame the typical range for Long-Term Debt Issuances.
• Across the five-year window, Long-Term Debt Issuances tumbled 99.97% in 2017 and soared 795346.26% in 2019, its largest moves.
• ProQR Therapeutics' Long-Term Debt Issuances stood at $117.74 in 2017, then jumped by 58.01% to $186.05 in 2018, then jumped by 795346.26% to $1.5 million in 2019, then slumped by 79.94% to $296880.2 in 2020, then jumped by 10111.27% to $30.3 million in 2021.
• According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $30.3 million, $334917.6, and $685230.4 for Q4 2021, Q3 2021, and Q2 2021 respectively.

Peer Comparison